...
首页> 外文期刊>Gastrointestinal Endoscopy >Carpe luz--seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium.
【24h】

Carpe luz--seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium.

机译:Carpe luz-抓住机遇:使用porfimer钠进行光动力疗法时,可预防食管腺癌。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Barrett's high-grade dysplasia is a difficult disease that mostly occurs in elderly patients with many medical problems. Often, these patients understand that esophageal cancer is a lethal disease but are unwilling to accept the mortality risks and long-term consequences associated with esophageal resection surgery. Indeed, many of these patients are not operative candidates. It is critically important that gastroenterologists and internists embrace their vital role in educating these patients about their treatment options. The study by Overholt et al firmly establishes the role of porfimer sodium PDT as the treatment of choice for patients with Barrett's high-grade dysplasia, with esophagectomy reserved for the 4% to 6% of patients who fail PDT. Carpe Lux-seize the light!
机译:巴雷特的高度不典型增生是一种困难的疾病,主要发生在有许多医疗问题的老年患者中。通常,这些患者理解食道癌是一种致死性疾病,但不愿接受与食道切除手术相关的死亡风险和长期后果。实际上,这些患者中有许多不是手术候选者。肠胃科医生和内科医生在教育这些患者有关其治疗选择的过程中发挥至关重要的作用至关重要。 Overholt等人的研究牢固地确立了porfimer钠PDT作为Barrett高度不典型增生患者的治疗选择的作用,食管切除术保留了PDT失败患者的4%至6%。 Carpe Lux-抓住光明!

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号